Clinical trial
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
NCT02683876 is registered in ClinicalTrials.gov with Mebo Research, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
- Lead sponsor
- Mebo Research, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- May 31, 2018
- Enrollment
- 39 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.